Because human SerpinA3 can also inhibit Cathepsin G (67), whether SerpinA3 can inhibit chronic adipose inflammation to ameliorate obesity and metabolic disorders by targeting Cathepsin G in humans merits further investigation. The gene discussed is CTSG; the disease is Other metabolic disease.